(4-methyl-3-nitrophenyl)(piperidin-1-yl)methanone, 1g

2-Bromo-5,6-dihydro-4H-cyclopenta[d]thiazole, 95.0%, 1g

Acide oxalique dihydraté, min 99,5 %, pa, ACS, ISO, 500 g, emballage plastique.

5-Chloro-7-fluoro-1H-indole-2-carboxylic acid, 97%, 250mg

2-Méthyl-1-butanol, min 97.5%, pour synthèse, 1L, conditionnement verre

5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine, 500mg

5-(acetylamino)-1-phenyl-1H-pyrazole-4-carboxylic acid, 95.0%, 250mg

15-Bromo-1-pentadecanol, 95.0%, 100mg

(2S,4S)-1-(tert-Butoxycarbonyl)-4-fluoro-2-pyrrolidinecarboxylic Acid>97.0%(T)200mg

5,5-Tetramethylenehydantoin, 95.0%, 25g

(6-Chloro-4-(cyclopropylamino)pyridin-3-yl)methanol, 1g

(S)-2-(2-(DIPHENYLPHOSPHINO)PHENYL)-4-PHENYL-4,5-DIHYDROOXAZOLE, 95%, 25g

METHYL 4-BROMO-2-METHYL-2H-INDAZOLE-6-CARBOXYLATE, 95.0%, 250mg